ROR2 blockade as a therapy for osteoarthritis. (2020)
Attributed to:
Neutrophil Vesicles as a novel autologous regenerative therapeutic for joint disease.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aax3063
PubMed Identifier: 32938794
Publication URI: http://europepmc.org/abstract/MED/32938794
Type: Journal Article/Review
Volume: 12
Parent Publication: Science translational medicine
Issue: 561
ISSN: 1946-6234